 | • レポートコード：MRC2Q12-16804 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥744,800 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,489,600 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ナノベース薬デリバリーシステムのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ナノベース薬デリバリーシステムのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ナノベース薬デリバリーシステムの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ナノベース薬デリバリーシステムのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのナノベース薬デリバリーシステムの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のナノベース薬デリバリーシステムの売上および2028年までの予測に焦点を当てています。 ナノベース薬デリバリーシステムのグローバル主要企業には、Amgen、Teva、Roche、UCB (Union Chimique Belge)、Celgene、Merck、Gilead Sciences、Sanofi、Pfizer、Takeda、Bausch&Lomb、Samyang Biopharmaceuticals、Johnson & Johnson、TOLMAR、Astellas、AMAG Pharmaceuticals、AbbVie、Dr Reddy、AstraZeneca、Aspen、Acrotech Biopharma、TWi Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ナノベース薬デリバリーシステム市場は、タイプとアプリケーションによって区分されます。世界のナノベース薬デリバリーシステム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 50nm以下、50-150nm、150-300nm、その他 【アプリケーション別セグメント】 親水性薬剤、疎水性薬剤 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ナノベース薬デリバリーシステム製品概要 - タイプ別市場（50nm以下、50-150nm、150-300nm、その他） - アプリケーション別市場（親水性薬剤、疎水性薬剤） - 調査の目的 ・エグゼクティブサマリー - 世界のナノベース薬デリバリーシステム販売量予測2017-2028 - 世界のナノベース薬デリバリーシステム売上予測2017-2028 - ナノベース薬デリバリーシステムの地域別販売量 - ナノベース薬デリバリーシステムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ナノベース薬デリバリーシステム販売量 - 主要メーカー別ナノベース薬デリバリーシステム売上 - 主要メーカー別ナノベース薬デリバリーシステム価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（50nm以下、50-150nm、150-300nm、その他） - ナノベース薬デリバリーシステムのタイプ別販売量 - ナノベース薬デリバリーシステムのタイプ別売上 - ナノベース薬デリバリーシステムのタイプ別価格 ・アプリケーション別市場規模（親水性薬剤、疎水性薬剤） - ナノベース薬デリバリーシステムのアプリケーション別販売量 - ナノベース薬デリバリーシステムのアプリケーション別売上 - ナノベース薬デリバリーシステムのアプリケーション別価格 ・北米市場 - 北米のナノベース薬デリバリーシステム市場規模（タイプ別、アプリケーション別） - 主要国別のナノベース薬デリバリーシステム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのナノベース薬デリバリーシステム市場規模（タイプ別、アプリケーション別） - 主要国別のナノベース薬デリバリーシステム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のナノベース薬デリバリーシステム市場規模（タイプ別、アプリケーション別） - 主要国別のナノベース薬デリバリーシステム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のナノベース薬デリバリーシステム市場規模（タイプ別、アプリケーション別） - 主要国別のナノベース薬デリバリーシステム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのナノベース薬デリバリーシステム市場規模（タイプ別、アプリケーション別） - 主要国別のナノベース薬デリバリーシステム市場規模（トルコ、サウジアラビア） ・企業情報 Amgen、Teva、Roche、UCB (Union Chimique Belge)、Celgene、Merck、Gilead Sciences、Sanofi、Pfizer、Takeda、Bausch&Lomb、Samyang Biopharmaceuticals、Johnson & Johnson、TOLMAR、Astellas、AMAG Pharmaceuticals、AbbVie、Dr Reddy、AstraZeneca、Aspen、Acrotech Biopharma、TWi Pharmaceuticals ・産業チェーン及び販売チャネル分析 - ナノベース薬デリバリーシステムの産業チェーン分析 - ナノベース薬デリバリーシステムの原材料 - ナノベース薬デリバリーシステムの生産プロセス - ナノベース薬デリバリーシステムの販売及びマーケティング - ナノベース薬デリバリーシステムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ナノベース薬デリバリーシステムの産業動向 - ナノベース薬デリバリーシステムのマーケットドライバー - ナノベース薬デリバリーシステムの課題 - ナノベース薬デリバリーシステムの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Nano-based Drug Delivery System estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Nano-based Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Nano-based Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Nano-based Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Nano-based Drug Delivery System include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Nano-based Drug Delivery System companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Nano-based Drug Delivery System market. Further, it explains the major drivers and regional dynamics of the global Nano-based Drug Delivery System market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Nano-based Drug Delivery System Segment by Type
Less than 50nm
50-150nm
150-300nm
Others
Nano-based Drug Delivery System Segment by Application
Hydrophilic Drugs
Hydrophobic Drugs
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nano-based Drug Delivery System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Nano-based Drug Delivery System market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Nano-based Drug Delivery System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nano-based Drug Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nano-based Drug Delivery System revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Nano-based Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Nano-based Drug Delivery System revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Nano-based Drug Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nano-based Drug Delivery System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nano-based Drug Delivery System revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano-based Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Less than 50nm
1.2.3 50-150nm
1.2.4 150-300nm
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nano-based Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hydrophilic Drugs
1.3.3 Hydrophobic Drugs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nano-based Drug Delivery System Market Perspective (2017-2028)
2.2 Nano-based Drug Delivery System Growth Trends by Region
2.2.1 Nano-based Drug Delivery System Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nano-based Drug Delivery System Historic Market Size by Region (2017-2022)
2.2.3 Nano-based Drug Delivery System Forecasted Market Size by Region (2023-2028)
2.3 Nano-based Drug Delivery System Market Dynamics
2.3.1 Nano-based Drug Delivery System Industry Trends
2.3.2 Nano-based Drug Delivery System Market Drivers
2.3.3 Nano-based Drug Delivery System Market Challenges
2.3.4 Nano-based Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano-based Drug Delivery System Players by Revenue
3.1.1 Global Top Nano-based Drug Delivery System Players by Revenue (2017-2022)
3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Players (2017-2022)
3.2 Global Nano-based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nano-based Drug Delivery System Revenue
3.4 Global Nano-based Drug Delivery System Market Concentration Ratio
3.4.1 Global Nano-based Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano-based Drug Delivery System Revenue in 2021
3.5 Nano-based Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Nano-based Drug Delivery System Product Solution and Service
3.7 Date of Enter into Nano-based Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano-based Drug Delivery System Breakdown Data by Type
4.1 Global Nano-based Drug Delivery System Historic Market Size by Type (2017-2022)
4.2 Global Nano-based Drug Delivery System Forecasted Market Size by Type (2023-2028)
5 Nano-based Drug Delivery System Breakdown Data by Application
5.1 Global Nano-based Drug Delivery System Historic Market Size by Application (2017-2022)
5.2 Global Nano-based Drug Delivery System Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nano-based Drug Delivery System Market Size (2017-2028)
6.2 North America Nano-based Drug Delivery System Market Size by Type
6.2.1 North America Nano-based Drug Delivery System Market Size by Type (2017-2022)
6.2.2 North America Nano-based Drug Delivery System Market Size by Type (2023-2028)
6.2.3 North America Nano-based Drug Delivery System Market Share by Type (2017-2028)
6.3 North America Nano-based Drug Delivery System Market Size by Application
6.3.1 North America Nano-based Drug Delivery System Market Size by Application (2017-2022)
6.3.2 North America Nano-based Drug Delivery System Market Size by Application (2023-2028)
6.3.3 North America Nano-based Drug Delivery System Market Share by Application (2017-2028)
6.4 North America Nano-based Drug Delivery System Market Size by Country
6.4.1 North America Nano-based Drug Delivery System Market Size by Country (2017-2022)
6.4.2 North America Nano-based Drug Delivery System Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nano-based Drug Delivery System Market Size (2017-2028)
7.2 Europe Nano-based Drug Delivery System Market Size by Type
7.2.1 Europe Nano-based Drug Delivery System Market Size by Type (2017-2022)
7.2.2 Europe Nano-based Drug Delivery System Market Size by Type (2023-2028)
7.2.3 Europe Nano-based Drug Delivery System Market Share by Type (2017-2028)
7.3 Europe Nano-based Drug Delivery System Market Size by Application
7.3.1 Europe Nano-based Drug Delivery System Market Size by Application (2017-2022)
7.3.2 Europe Nano-based Drug Delivery System Market Size by Application (2023-2028)
7.3.3 Europe Nano-based Drug Delivery System Market Share by Application (2017-2028)
7.4 Europe Nano-based Drug Delivery System Market Size by Country
7.4.1 Europe Nano-based Drug Delivery System Market Size by Country (2017-2022)
7.4.2 Europe Nano-based Drug Delivery System Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nano-based Drug Delivery System Market Size (2017-2028)
8.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Type
8.2.1 Asia-Pacific Nano-based Drug Delivery System Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nano-based Drug Delivery System Market Share by Type (2017-2028)
8.3 Asia-Pacific Nano-based Drug Delivery System Market Size by Application
8.3.1 Asia-Pacific Nano-based Drug Delivery System Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nano-based Drug Delivery System Market Share by Application (2017-2028)
8.4 Asia-Pacific Nano-based Drug Delivery System Market Size by Region
8.4.1 Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nano-based Drug Delivery System Market Size (2017-2028)
9.2 Latin America Nano-based Drug Delivery System Market Size by Type
9.2.1 Latin America Nano-based Drug Delivery System Market Size by Type (2017-2022)
9.2.2 Latin America Nano-based Drug Delivery System Market Size by Type (2023-2028)
9.2.3 Latin America Nano-based Drug Delivery System Market Share by Type (2017-2028)
9.3 Latin America Nano-based Drug Delivery System Market Size by Application
9.3.1 Latin America Nano-based Drug Delivery System Market Size by Application (2017-2022)
9.3.2 Latin America Nano-based Drug Delivery System Market Size by Application (2023-2028)
9.3.3 Latin America Nano-based Drug Delivery System Market Share by Application (2017-2028)
9.4 Latin America Nano-based Drug Delivery System Market Size by Country
9.4.1 Latin America Nano-based Drug Delivery System Market Size by Country (2017-2022)
9.4.2 Latin America Nano-based Drug Delivery System Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano-based Drug Delivery System Market Size (2017-2028)
10.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Type
10.2.1 Middle East & Africa Nano-based Drug Delivery System Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nano-based Drug Delivery System Market Share by Type (2017-2028)
10.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Application
10.3.1 Middle East & Africa Nano-based Drug Delivery System Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nano-based Drug Delivery System Market Share by Application (2017-2028)
10.4 Middle East & Africa Nano-based Drug Delivery System Market Size by Country
10.4.1 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Nano-based Drug Delivery System Introduction
11.1.4 Amgen Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.1.5 Amgen Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Nano-based Drug Delivery System Introduction
11.2.4 Teva Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.2.5 Teva Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Nano-based Drug Delivery System Introduction
11.3.4 Roche Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.3.5 Roche Recent Developments
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Details
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.4.5 UCB (Union Chimique Belge) Recent Developments
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Nano-based Drug Delivery System Introduction
11.5.4 Celgene Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.5.5 Celgene Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Nano-based Drug Delivery System Introduction
11.6.4 Merck Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Nano-based Drug Delivery System Introduction
11.7.4 Gilead Sciences Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.7.5 Gilead Sciences Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Nano-based Drug Delivery System Introduction
11.8.4 Sanofi Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.8.5 Sanofi Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nano-based Drug Delivery System Introduction
11.9.4 Pfizer Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.9.5 Pfizer Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Nano-based Drug Delivery System Introduction
11.10.4 Takeda Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.10.5 Takeda Recent Developments
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Details
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Nano-based Drug Delivery System Introduction
11.11.4 Bausch&Lomb Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.11.5 Bausch&Lomb Recent Developments
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Details
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.12.5 Samyang Biopharmaceuticals Recent Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Nano-based Drug Delivery System Introduction
11.13.4 Johnson & Johnson Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.13.5 Johnson & Johnson Recent Developments
11.14 TOLMAR
11.14.1 TOLMAR Company Details
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Nano-based Drug Delivery System Introduction
11.14.4 TOLMAR Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.14.5 TOLMAR Recent Developments
11.15 Astellas
11.15.1 Astellas Company Details
11.15.2 Astellas Business Overview
11.15.3 Astellas Nano-based Drug Delivery System Introduction
11.15.4 Astellas Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.15.5 Astellas Recent Developments
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Details
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.16.5 AMAG Pharmaceuticals Recent Developments
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Nano-based Drug Delivery System Introduction
11.17.4 AbbVie Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.17.5 AbbVie Recent Developments
11.18 Dr Reddy
11.18.1 Dr Reddy Company Details
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Nano-based Drug Delivery System Introduction
11.18.4 Dr Reddy Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.18.5 Dr Reddy Recent Developments
11.19 AstraZeneca
11.19.1 AstraZeneca Company Details
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Nano-based Drug Delivery System Introduction
11.19.4 AstraZeneca Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.19.5 AstraZeneca Recent Developments
11.20 Aspen
11.20.1 Aspen Company Details
11.20.2 Aspen Business Overview
11.20.3 Aspen Nano-based Drug Delivery System Introduction
11.20.4 Aspen Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.20.5 Aspen Recent Developments
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Details
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Introduction
11.21.4 Acrotech Biopharma Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.21.5 Acrotech Biopharma Recent Developments
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Details
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Introduction
11.22.4 TWi Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.22.5 TWi Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
| 【ナノベース薬デリバリーシステムについて】 ※ナノベース薬デリバリーシステムは、ナノテクノロジーを基盤にした医薬品の投与方法であり、薬物の効果を最大限に引き出すための革新的なアプローチです。これにより、薬物の生物学的利用能を高め、特に難治性疾患に対する治療の新たな可能性を開くことが期待されています。本システムは、ナノサイズのキャリアを利用して医薬品を標的部位に効果的に運ぶことができるため、従来の薬物投与法に比べ、より効果的かつ安全な治療が可能となります。 この薬デリバリーシステムの主な特徴の一つは、ナノスケールでの操作が可能なことであり、これにより、薬物の放出速度や吸収性、ターゲティング能力を向上させることができます。ナノキャリアとして使用される材料には、リポソーム、ポリマー、金属ナノ粒子、ナノクリスタル、ナノカプセルなどがあります。それぞれの材料は、異なる特性を持ち、さまざまな疾患に応じた薬物放出のための適切な方法が開発されています。 ナノベース薬デリバリーシステムには、主に二つのアプローチがあります。一つは「順次放出型システム」、もう一つは「ターゲティングシステム」です。前者は、薬物が時間をかけて徐々に放出されることにより、持続的な効果をもたらします。後者は、特定の細胞や組織に対してピンポイントで薬物を届けることを目的としており、主に疾病特異的なマーカーを利用してターゲティングを行います。これにより、治療効果を最大化し、副作用を最小限に抑えることが期待されます。 利用用途については、主に癌治療、感染症、自己免疫疾患、神経疾患など、多岐にわたります。特に癌に対するナノベース薬剤は、その特異的な標的化能力により、腫瘍細胞に直接攻撃を行うことができるため、従来の抗癌剤に比べて顕著な効果を発揮する研究が進められています。さらに、ナノデリバリーシステムは、遺伝子治療やワクチンのデリバリーにも応用されており、この分野でも大きな期待が寄せられています。 ナノベース薬デリバリーシステムの関連技術としては、ドラッグデリバリーに関わるさまざまなナノマテリアルの開発や合成技術が挙げられます。これらの材料の設計には、高い生体適合性、安定性、そして選択的な放出機能が求められます。さらに、ナノ材料の合成には、化学的手法、生物学的手法、物理的手法があり、それぞれの手法は異なる特性を持つナノキャリアの開発に寄与しています。また、3Dプリンティング技術を用いた個別化医療の実現にむけた研究も進行中であり、患者ごとの特性に合わせた薬物投与が可能になることが期待されています。 また、医療分野だけでなく、ナノテクノロジーの進展は他の分野においても多くの可能性を秘めています。例えば、環境浄化やエネルギー分野における応用も進んでおり、ナノ材料を利用した新たな解決策が提案されています。これにより、医療だけでなく、さまざまな産業分野においてもナノベース技術の重要性が増していくことでしょう。 総じて、ナノベース薬デリバリーシステムは、医療における新たな治療法としての可能性を秘めており、今後の研究と開発が期待されています。特に、個別化医療の発展や新しい治療戦略の確立に寄与することで、患者に対するより良い治療成果をもたらすことができるでしょう。ナノテクノロジーの進展がもたらす多様な可能性を最大限に活用することが、今後の医療の未来を切り拓く鍵となると考えられます。 |